The logistics behind delivering medicines and treatments are more important than ever. As the sector evolves with new technologies, production methods, and shifting trends, companies need reliable data to make informed decisions.
Pharma.Aero is preparing to launch its latest initiative, Pharmalytics, emerging from a need to make sense of the overwhelming data generated in the sector. This ambitious project promises to revolutionise the way logistics executives within the pharmaceutical industry access, analyse, and apply data.
“We saw a recurrent pattern during the Masterclass. Day One typically starts with ‘setting the scene’, evaluating the economy, pharmaceutical production, and the flows within the industry. But we realised there was a wealth of valuable information that people were referring to after they left. It was so useful for understanding market trends, regulatory factors, and even external influences like geopolitical stress,” Frank Van Gelder, Secretary General of Pharma.Aero, said.
“We thought, why not level this up? There’s nothing like it available, so we decided to gather data from trustworthy sources and create our own insights. This way, we could provide conclusive reports with a deeper understanding of the landscape.”
What is Pharmalytics?
Pharmalytics is designed to support logistics executives in the pharmaceutical industry by offering comprehensive, data-driven insights. The aim is to integrate a variety of sources, enabling companies to optimise their supply chains. “We’ll be looking at two main areas: production and the logistics or supply chain impact,” Van Gelder explained.
One of the key components of the Pharmalytics reports will be data on market evolution – “Which countries are increasing production? Who is investing more in R&D? These trends directly influence the logistics behind them,” he noted.
The project will focus on current trends and future developments, providing the foresight needed to adapt to a rapidly evolving landscape. In addition to production and logistics data, it will also take a deep dive into ecosystem analysis.
“How is the supply chain structured today, and what will it look like tomorrow?” Van Gelder posed, highlighting how the reports will map out how supply chains might evolve.
“The hospital is becoming the home… We’re seeing a trend where patient care is moving to home settings, which means we need to rethink logistics strategies, possibly even integrating e-commerce models into pharmaceutical deliveries.”
Cross-industry data
Pharmalytics isn’t just about numbers; it’s about synthesising information from multiple disciplines and industries, with Van Gelder likened it to creating a “top-quality meal in your kitchen.”
“You might make a nice dish or bake a loaf of bread, but the real magic happens when you combine all the ingredients correctly. Pharmalytics is designed to bring together healthcare, market, economic, and logistics data into one comprehensive report.”
“Often, data is angled in one direction or another,” Van Gelder said. “But Pharmalytics will bring different worlds together, providing a holistic view.”
While the initial reports will be valuable, they are just the beginning, Van Gelder emphasised. “It’s like the first Ferrari or Mercedes-Benz, those early models weren’t as good or as safe as the cars we have today. We’ll start on a critical basis, but with further development, we hope to achieve capabilities that will set Pharmalytics apart.
“Pharmalytics is about more than just statistics. It’s about applying data in a way that’s meaningful and useful to the industry.”
